Explore Coeur Mining’s new mid‑cap benchmark spot, its FY‑2025 performance, ESG challenges, and green‑bond prospects – a deep dive into the future of U.S. gold & silver mining.
Explore the latest third‑generation EGFR TKI and JAK1‑PD‑L1 combo in NSCLC—evidence of stronger tumor shrinkage, CNS activity, and lower irAEs could reshape lung‑cancer treatment.
Explore why Coeur Mining’s recent rally may be overvalued. Understand the company’s solid fundamentals, commodity risks, and long‑term prospects before investing.
Coeur Mining’s debt swap and New Gold acquisition unlock a $1 bn credit line, broaden gold‑silver‑copper output, and boost shareholder value for 2026.